RxDoctor Payments Data

Loren Calderone, NP

Family · Mishawaka, INNPI 1437763299

Payments from drug & device makers

$2,061in general payments, 2019–2025

Across 88 payments — averaging $23.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$350
  • AstraZeneca$308
  • Otsuka America Pharmaceutical, Inc.$264
  • Fresenius USA Marketing, Inc.$214
  • Bayer$188
  • Amgen$115
  • plus $622 from 14 others

What the payments were for

  • Food & beverage$1,89792%
  • Education$1648%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,061 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$22,150
Medicare patients
255
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide84$195,216
FosrenolLanthanum Carbonate21$36,017
VeltassaPatiromer Calcium Sorbitex27$30,362
FarxigaDapagliflozin Propanediol33$23,253
Sevelamer Carbonate128$11,387
Lanthanum Carbonate13$10,098
Midodrine Hcl70$3,879
Calcium Acetate15$788
Torsemide38$770
Lidocaine-PrilocaineLidocaine/Prilocaine38$703
Hydralazine Hcl46$544
Doxazosin Mesylate22$501
Amlodipine Besylate80$473
Nifedipine ErNifedipine11$433
Lisinopril75$338

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$214$195,21684 claims
AstraZenecaFarxiga$308$23,25333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.

Other family in Mishawaka

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →